Tradition Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-313
Closed -$11K 1140
2022
Q1
$11K Hold
313
﹤0.01% 883
2021
Q4
$13K Hold
313
﹤0.01% 850
2021
Q3
$14K Hold
313
﹤0.01% 823
2021
Q2
$15K Hold
313
﹤0.01% 834
2021
Q1
$16K Hold
313
﹤0.01% 686
2020
Q4
$16K Buy
+313
New +$14.9K ﹤0.01% 637

Other funds holding SBIO

Tradition Wealth Management's SBIO Position: Q2 2022 in Review

Tradition Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2022, closing a stake of 313 shares — an estimated $11K sold.

Tradition Wealth Management first reported a position in SBIO in Q4 2020 and held it in 6 quarters. The position peaked at $16K in Q1 2021. 52 funds tracked by Wall St. Rank hold SBIO as of Q2 2022.

  • Tradition Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2022 after selling out during the quarter.
  • Tradition Wealth Management sold 313 ALPS Medical Breakthroughs ETF shares in Q2 2022, an estimated $11K.
  • Tradition Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and held it in 6 quarters.
  • Tradition Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $16K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2022.

Based on Tradition Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.